Te­va to pay $450M to set­tle al­le­ga­tions of kick­backs and gener­ic drug price-fix­ing

Gener­ics gi­ant Te­va Phar­ma­ceu­ti­cals will pay $450 mil­lion over six years to set­tle two al­le­ga­tions that the com­pa­ny vi­o­lat­ed the An­ti-Kick­back Statute and the False …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA